Rijuven Corporation: commercialize medical devices that have a world impact - iCrowdNewswire

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Global Regions ( XML Feed )
United States ( XML Feed )

Oct 6, 2015 12:00 PM ET

Rijuven Corporation: commercialize medical devices that have a world impact

iCrowdNewswire - Oct 6, 2015

Rijuven Corporation

Rijuven Corporation Logo


Rijuven, founded in 2012 by Raj Kapoor, MD, FCCP and Evens Augustin, was created to commercialize medical devices that have a world impact.

We are a team of clinicians, technologists, designers, innovation strategist, patients and consumers that have come together to create compelling products. Rijuven has set out on a mission to transform medical device markets and revolutionize care delivery through the use of select innovations that increase outcomes, drive down costs and expand care access.


Products / Services


i2Dtx is a comprehensive and accurate cloud based medical device platform you can wirelessly deploy to assess your patients at any point of care.

i2Dtx streamlines diagnosis at an affordable cost by deploying heart, lung, cardiovascular, vital signs, imaging and lab clinical assessments for any physical examination

Cardio Sleeve

i2Dtx CardioSleeve is the first FDA cleared stethoscope add-on device for clinicians to acquire 3-Lead ECG and Digital Heart Sound at any point of care.

CardioSleeve enhances the traditional stethoscope by recording, displaying and analyzing the heart’s ECG and acoustical footprints, synchronized, in real time via any wirelessly connected portable device.


i2Ptm is an FDA Registered chest-worn patch that continuously monitors bed position, motion, falls, heart rate, and breathing rate.
i2Ptm monitors patient bed position changes and provides clinical staff with alerts and notifications when a reposition should be made.
By monitoring the patient, not the bed, the i2Ptm monitors bed exits, falls and other mobility that may cause harm or concern. Vitals are recorded in real time.

Contact Information:

Dean Rodriguez

View Related News >